Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection, and post administration monitoring in the home or residence. This includes a beneficiary's home that has been made provider-based to the hospital during the covid-19 public health emergency, subsequent repeat doses
| Insurance Carrier | Facility/Professional | Modifier | Low Price | Median Price | High Price |
|---|---|---|---|---|---|
BCBS
| Facility | $2,805.00 | $6,000.00 | $12,015.00 | |
Cigna
| Facility | $750.00 | $750.00 | $753.75 | |
Cigna
| Professional | $750.00 | $750.00 | $937.50 | |
United
| Professional | $975.00 | $1,147.17 | $1,147.17 |
Want provider-level rates data? We offer custom data extracts for a reasonable fee. To learn more, please email us.